Margo Feeney

University of California, San Francisco (UCSF) - Department of Medicine

San Francisco, CA

United States

  • University of California, San Francisco (UCSF) - Department of Medicine

SCHOLARLY PAPERS

5

DOWNLOADS

135

TOTAL CITATIONS

0

Scholarly Papers (5)

Actions:
Email selected abstracts
1.

Malaria-Specific Type 1 Regulatory T Cells are More Abundant in First Pregnancies and Associated with Placental Malaria

Number of pages: 51 Posted: 27 May 2023
Adam Setori Kirosingh, Alea Delmastro, Abel Kakuru, Kattria van der Ploeg, Sanchita Bhattacharya, Kathleen D. Press, Maureen Caracena Ty, Lauren de la Parte, Jimmy Kizza, Mary Muhindo, Sebastien Devachannee, Benoit Gamain, Felistas Nankya, Kenneth Musinguzi, Philip J. Rosenthal, Margo Feeney, Moses Kamya, Grant Dorsey and Prasanna Jagannathan
Stanford University - School of Medicine, Stanford University, Infectious Diseases Research Collaboration (Uganda), Stanford University - Infectious Disease Division, University of California, San Francisco (UCSF), Stanford University - School of Medicine, Stanford University - School of Medicine, Stanford University - School of Medicine, Makerere University, Infectious Diseases Research Collaboration (Uganda), Université Paris Cité, Université Paris Cité, Infectious Diseases Research Collaboration (Uganda), Infectious Diseases Research Collaboration (Uganda), University of California, San Francisco (UCSF) - Department of Medicine, University of California, San Francisco (UCSF) - Department of Medicine, Infectious Diseases Research Collaboration (Uganda), University of California, San Francisco (UCSF) - Department of Medicine and Stanford University - Department of Microbiology and Immunology
Downloads 64 (696,104)

Abstract:

Loading...

Malaria, Pregnancy, Gravidity, CD4+ T Cells, Placental Malaria, Immunity

2.

Highly Potent Naturally Acquired Human Monoclonal Antibodies Against Pfs48/45 Block Plasmodium falciparum Transmission to Mosquitoes

Number of pages: 57 Posted: 07 Sep 2022
Amanda Fabra-Garcia, Sophia Hailemariam, Roos de Jong, Kirsten Janssen, Karina Teelen, Marga van de Vegte-Bolmer, Geert-Jan van Gemert, Danton Ivanochko, Anthony Semesi, Brandon McLeod, Martijn Vos, Marloes de Bruijni, Judith Bolscher, Marta Szabat, Stefanie Vogt, Lucas Kraft, Sherie Duncan, Moses Kamya, Margo Feeney, Prasanna Jagannathan, Bryan Greenhouse, Koen Dechering, Robert W. Sauerwein, C. Richter King, Randall MacGill, Teun Bousema, Jean-Philippe Julien and Matthijs M. Jore
Radboud University Nijmegen - Department of Medical Microbiology, University of Toronto - Program in Molecular Medicine, Radboud University Nijmegen - Department of Medical Microbiology, Radboud University Nijmegen - Department of Medical Microbiology, Radboud University Nijmegen - Department of Medical Microbiology, Radboud University Nijmegen - Department of Medical Microbiology, Radboud University Nijmegen - Department of Medical Microbiology, University of Toronto - Program in Molecular Medicine, University of Toronto - Program in Molecular Medicine, University of Toronto - Program in Molecular Medicine, TropIQ Health Sciences, TropIQ Health Sciences, TropIQ Health Sciences, AbCellera Biologics Inc., AbCellera Biologics Inc., AbCellera Biologics Inc., AbCellera Biologics Inc., Infectious Diseases Research Collaboration (Uganda), University of California, San Francisco (UCSF) - Department of Medicine, Stanford University - Department of Microbiology and Immunology, University of California, San Francisco (UCSF) - Department of Medicine, TropIQ Health Sciences, TropIQ Health Sciences, PATH's Malaria Vaccine Initiative, PATH's Malaria Vaccine Initiative, Radboud University Nijmegen - Department of Medical Microbiology, Hospital for Sick Children Research Institute - Program in Molecular Medicine and Radboud University Nijmegen - Department of Medical Microbiology
Downloads 26 (982,471)

Abstract:

Loading...

Malaria, Plasmodium falciparum, Human monoclonal antibodies, Crystallography, Pfs48/45, Transmission reducing activity, Transmission blocking vaccine

3.

Identification of Highly Potent Transmission-Blocking Human Monoclonal Antibodies to Plasmodium falciparum Pfs230 in Naturally Exposed Individuals

Number of pages: 51 Posted: 08 Sep 2022
Danton Ivanochko, Amanda Fabra-García, Karina Teelen, Marga van de Vegte-Bolmer, Geert-Jan van Gemert, Jocelyn Newton, Anthony Semesi, Marloes de Bruijni, Judith Bolscher, Jordache Ramjith, Marta Szabat, Stefanie Vogt, Lucas Kraft, Sherie Duncan, Shwu-Maan Lee, Moses Kamya, Margo Feeney, Prasanna Jagannathan, Bryan Greenhouse, Robert W. Sauerwein, C. Richter King, Randall MacGill, Teun Bousema, Matthijs M. Jore and Jean-Philippe Julien
University of Toronto - Program in Molecular Medicine, Radboud University Nijmegen - Department of Medical Microbiology, Radboud University Nijmegen - Department of Medical Microbiology, Radboud University Nijmegen - Department of Medical Microbiology, Radboud University Nijmegen - Department of Medical Microbiology, University of Toronto - Program in Molecular Medicine, University of Toronto - Program in Molecular Medicine, TropIQ Health Sciences, TropIQ Health Sciences, Radboud University Nijmegen - Radboud Institute for Health Sciences, AbCellera Biologics Inc., AbCellera Biologics Inc., AbCellera Biologics Inc., AbCellera Biologics Inc., PATH's Malaria Vaccine Initiative, Infectious Diseases Research Collaboration (Uganda), University of California, San Francisco (UCSF) - Department of Medicine, Stanford University - Department of Microbiology and Immunology, University of California, San Francisco (UCSF) - Department of Medicine, TropIQ Health Sciences, PATH's Malaria Vaccine Initiative, PATH's Malaria Vaccine Initiative, Radboud University Nijmegen - Department of Medical Microbiology, Radboud University Nijmegen - Department of Medical Microbiology and Hospital for Sick Children Research Institute - Program in Molecular Medicine
Downloads 22 (1,026,345)

Abstract:

Loading...

Human monoclonal antibodies, malaria, natural infection, Plasmodium falciparum, transmission-blocking, Pfs230

4.

Disease Tolerance of Malaria Involves Epigenetic Reprogramming of Innate Immune Cells

Number of pages: 47 Posted: 05 May 2023
Jason Nideffer, Maureen Caracena Ty, Michele Donato, Rek John, Richard Kajubi, Xuhuai Ji, Felistas Nankya, Kenneth Musinguzi, Kathleen D. Press, Bryan Greenhouse, Moses Kamya, Margo Feeney, Grant Dorsey, PJ Utz, Bali Pulendran, Purvesh Khatri, Prasanna Jagannathan and Sneak Peek Administrator
Stanford University - School of Medicine, Stanford University - School of Medicine, Stanford University - School of Medicine, Infectious Diseases Research Collaboration (Uganda), Infectious Diseases Research Collaboration (Uganda), Stanford University - Department of Microbiology and Immunology, Infectious Diseases Research Collaboration (Uganda), Infectious Diseases Research Collaboration (Uganda), Stanford University - School of Medicine, University of California, San Francisco (UCSF) - Department of Medicine, Infectious Diseases Research Collaboration (Uganda), University of California, San Francisco (UCSF) - Department of Medicine, University of California, San Francisco (UCSF) - Department of Medicine, Stanford University - School of Medicine, Stanford University - Institute for Immunity, Transplantation, and Infection, Stanford University - Institute for Immunity, Transplantation, and Infection, Stanford University - Department of Microbiology and Immunology and Independent
Downloads 12 (1,147,456)

Abstract:

Loading...

malaria, disease tolerance, naturally acquired immunity, epigenetics, innate immune memory

5.

A Cytotoxic-Skewed Immune Set Point Predicts Low Neutralizing Antibody Levels After Zika Virus Infection

Number of pages: 63 Posted: 10 Feb 2022
Elizabeth E. McCarthy, Pamela Odorizzi, Emma Lutz, Carolyn Smullin, Iliana Tenvooren, Mars Stone, Graham Simmons, Peter Hunt, Margo Feeney, Philip Norris, Michael Busch, Matthew H. Spitzer and Rachel L. Rutishauser
University of California, San Francisco (UCSF) - Departments of Otolaryngology-Head and Neck Surgery and of Microbiology and Immunology, University of California, San Francisco (UCSF) - Department of Medicine, University of California, San Francisco (UCSF) - Department of Medicine, University of California, San Francisco (UCSF) - Department of Medicine, University of California, San Francisco (UCSF) - Departments of Otolaryngology-Head and Neck Surgery and of Microbiology and Immunology, Vitalant Research Institute, Vitalant Research Institute, University of California, San Francisco (UCSF) - Department of Medicine, University of California, San Francisco (UCSF) - Department of Medicine, Vitalant Research Institute, Vitalant Research Institute, University of California, San Francisco (UCSF) - Departments of Otolaryngology-Head and Neck Surgery and of Microbiology and Immunology and University of California, San Francisco (UCSF) - Department of Medicine
Downloads 11 (1,159,929)

Abstract:

Loading...

Zika virus, neutralizing antibodies, CyTOF, immune signatures